Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2018, Article ID 6515670, 8 pages
https://doi.org/10.1155/2018/6515670
Research Article

Microbiota Composition in Upper Respiratory Tracts of Healthy Children in Shenzhen, China, Differed with Respiratory Sites and Ages

1Department of Respiratory Diseases, Shenzhen Children’s Hospital, Shenzhen 518026, China
2Department of Computer Science, City University of Hong Kong, Kowloon Tong 999077, Hong Kong
3Department of Microbial Research, WeHealthGene, Shenzhen 518000, China
4Department of Infectious Diseases, Shenzhen Children’s Hospital, Shenzhen 518026, China

Correspondence should be addressed to Yuejie Zheng; moc.anis@0991enihs

Received 21 November 2017; Revised 7 May 2018; Accepted 24 May 2018; Published 14 June 2018

Academic Editor: Gernot Zissel

Copyright © 2018 Heping Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

The upper respiratory tract (URT) is home to various microbial commensals, which function as competitors to pathogens and help train the immune system. However, few studies have reported the normal microbiota carriage in the URT of healthy Chinese children. In this study, we performed a 16S rDNA gene sequencing analysis of 83 anterior nares (ANs), 60 nasopharynx (NP), and 97 oropharynx (OP) samples from 98 healthy children in Shenzhen, China (≤12 years of age). The microbiota in ANs and NP is the same at different ages and typical species in these sites include Moraxella, Staphylococcus, Corynebacterium, Streptococcus, and Dolosigranulum. By contrast, the OP is primarily colonized by Streptococcus, Prevotella, Neisseria, Veillonella, Rothia, Leptotrichia, and Haemophilus. Streptococcus and Rothia keep low abundance in OP microbiota of children1 year old, whereas Prevotella, Neisseria, Haemophilus, and Leptotrichia amass significantly in individuals >1 year old. This work furnishes an important reference for understanding microbial dysbiosis in the URT of Chinese paediatric patients.

1. Introduction

The upper respiratory tract (URT) functions as an interface between exterior environment, lung, and gastrointestinal tract [1]. Several reports have demonstrated that the normal microbiota of the URT confers colonization resistance against pathogen intrusion and performs immune education [2, 3]. The lipopolysaccharide (LPS) of Prevotella antagonized the LPS produced by Haemophilus influenzae and inhibited Toll-like receptor 4- (TLR4-) mediated mucosal inflammation [4]. Th17 immune responses were activated by commensal bacteria and active metabolic products that primed mucosal immunity against respiratory pathogen colonization [5]. Various immune responses can be also induced by specific clearance mechanism of different pathogens [6, 7]. The expression level of interleukin 8 (IL-8) in pulmonary epithelial cells increased after exposure to Moraxella [8]. The expression of IL-6 and interferon γ (IFN-γ) mounted highly to inhibit the virus-associated inflammation [9, 10]. These findings suggest a significant role of URT commensals in immune maturation and clearing pathogens.

The URT microbiota varies dramatically with niches and developmental stages [2, 1113]. Previous study [14] found that the nasopharyngeal microbiota differentiated as early as 1 week of age and stabilized after 6 weeks, with a predominance of Moraxella, Dolosigranulum, and Corynebacterium. Dominant Haemophilus/Streptococcus in nasopharyngeal microbiota indicated high incidence of respiratory infections [14]. A one-year longitudinal study on newborn infants indicated that the nasal microbiota was primarily shaped by age, with increasing bacterial density and decreasing diversity [15].

By comparison with healthy European and American children, URT microbiota in healthy Chinese children remains little explored. In this study, we conducted 16S rDNA analysis of 240 URT samples from 98 healthy children in Shenzhen where an increasing number of young families are residing in. We aimed to profile microbiota structure at anterior nares (ANs), nasopharynx (NP), and oropharynx (OP) as well as to conduct comparison among samples with different ages.

2. Material and Methods

2.1. Subjects Selection

Children were recruited to an examination room in Shenzhen Children’s Hospital and all the volunteers’ families were indigenous residents in different regions of Shenzhen. The inclusion criteria requested no asthma and family history of allergy, no history of pneumonia, no cough, fever or other respiratory/allergic symptoms one month before sampling, no respiratory infection and antibiotic exposure for at least 1 month prior to the study, and no respiratory symptoms 1 week after sampling.

2.2. Sample Preparation and Sequencing

NP, OP, and ANs microbial samples were collected by an experienced clinician with specific swabs (25-800-A-50, Puritan, Guilford, USA; 155C, COPAN, Murrieta, USA). The swabs, which were unused or opened in the sampling room for several seconds, were served as negative controls to evaluate potential contamination. All samples were stored at -80°C within 20 minutes after sampling.

DNA extraction was performed by PowerSoil® DNA Isolation Kit (MO BIO Laboratories). The DNA library of 16S rDNA V3-V4 region was constructed by the PCR amplification and sequenced on Illumina MiSeq Sequencing platform. All sequencing data were deposited in GenBank database under accession number SRP090593.

2.3. Bioinformatics Analysis

Raw sequencing data were processed through QIIME pipeline [16]. Data filtration, operational taxonomic units (OTUs) clustering, taxonomic classification, and diversity calculation were conducted following our previous study [17]. The same number of tags was utilized to construct rarefaction curve and assess the sequencing saturation of each sample. The confounding effects of various characteristics on bacterial composition were evaluated by the PERMANOVA [18]. URTs microbial samples were clustered following previous studies [11, 19, 20]. Bray-Curtis dissimilarity was employed to assess the similarity between microbial samples. Microbiota comparison between two URT sites was conducted through Wilcoxon rank-sum test and adjusted by false discovery rate (FDR) (q-value). All graphs were prepared by R (v3.2.3) (packages ‘ggplot2’ and ‘NMF’) and SVG (v1.1).

3. Results

3.1. Sample Characteristics, Data Output, and Confounder Analysis

In this study, we totally enrolled 115 children aged ≤12 years old in Shenzhen Children’s Hospital through health examination. Ninety-eight children (50 girls and 48 boys) were selected after health examination and at least one-week follow-up (Table 1, Supplementary Table 1).

Table 1: Sample information.

The concentration of extracted DNA in the unused sampling swabs and DNA extraction kits was lower than 0.01 ng/μl, whereas it was higher than 80 ng/μl in sampling swabs. In addition, 16S rRNA gene amplification on the extracted DNA exhibited less than 0.01 nmol/l bacterial DNA in the enveloped sampling or extraction materials, indicating negligible DNA contamination from sampling and DNA extraction materials.

High-quality tags produced from the ANs, NP, and OP microbial samples averaged 42,195 (17,102-68,499), 42,698 (19,923-88,084), and 32,331 (17,112-56,071) (Supplementary Figure 1), and the number of OTUs at ANs, NP, and OP averaged 250, 235, and 102, respectively. Confounder analysis indicated that age is the most significant factor to explain variations in microbial samples at each site (p-values for ANs, NP, and OP are 0.003, 0.013, and 0.001, respectively) (Supplementary Table 2).

3.2. ANs and NP Tend to Harbour a Similar Microbiota with Different Ages and the OP Differs from Them

Corynebacterium, Streptococcus, Staphylococcus, Moraxella, and Dolosigranulum dominate the ANs and NP microbiota while the dominant bacterial components at OP differ (Figure 1(a)). PCA indicates that ANs and NP microbial samples cluster differently compared to OP microbial samples (Figure 1(b)).

Figure 1: Microbial flora in the ANs, NP, and OP are differentiated at different ages. (a) The top 5 genera among the ANs and NP were Moraxella, Staphylococcus, Corynebacterium, Streptococcus, and Dolosigranulum, and OP harboured different dominant genera. (b) The microbiota composition of the OP remained different from those of the ANs and NP. In each subgroup ((c) ≤1 year old; (d) >1 and ≤3 years old; (e) >3 and ≤6 years old; (f) >6 years old), all OP samples exhibited an independent cluster other than mixed ANs and NP. Each genus was painted with specific colours.

To further understand whether the ANs and NP microbiota were differentiated at specific age, microbial samples were stratified to four subgroups: ≤1 year old (21 children), >1 and ≤3 years old (28 children), >3 and ≤6 years (25 children) old, and >6 years old (24 children) (Figures 1(c)1(f)). The dissimilarity between ANs and NP microbial samples is lower than that between ANs and OP microbial samples in each subgroup (Supplementary Figure 2). Moreover, OP microbial samples in each subgroup tend to be found in one cluster while ANs and NP microbial samples are clustered closely (Figures 1(c)1(f)).

3.3. Predominant Microbial Phyla and Genera in the OP Differ Significantly from That in ANs and NP

Firmicutes are the dominant phyla in the ANs, NP, and OP microbiota (Supplementary Table 3). Actinobacteria account for 7.9%, 27.1%, and 12.5% of the OP, ANs, and NP microbiota, respectively (Supplementary Table 3). Bacteroidetes in the OP microbiota are 4.94-/2.68-fold higher than that in the ANs/NP (q-values <0.001) (Supplementary Table 3).

Moraxella, Staphylococcus, Corynebacterium, Streptococcus, and Dolosigranulum totally represent 65.6–77.2% of the ANs or NP microbiota (Figure 1(a), Supplementary Table 4). The predominant bacterial components at OP are Streptococcus, followed by Prevotella, Neisseria, Veillonella, and Haemophilus, the sum of which only account for <10% in the ANs/NP microbiota (Figure 1(a)).

3.4. OP Microbiota Develops Dramatically during First Year and Then Turns to Be Stable

The diversity of the OP microbiota increased dramatically in the first year (p-value <0.001) and kept stable after one year old (Figure 2(a)). By contrast, the bacterial diversity in ANs and NP microbiota revealed less change than that in OP microbiota (Figure 2(a)).

Figure 2: Microbial diversity in the ANs, NP, and OP at different ages and dominated genera in the OP of children ≤1, >1 and ≤3, or >3 years old. (a) The microbial diversity in the OP increased significantly during the first year of life and then remained stable, ANs and NP shown to be similar microbial diversity at different age. NS, , and represent p-value >0.05, ≤0.05, and ≤0.001, respectively. (b) Structure of dominant genera based on relative abundance. Each circle represents genus with total relative abundance in the three groups, and the width of line represents genus with the relative abundance in each group. and represent q-value of Kruskal-Wallis test ⩽ 0.01 and ⩽ 0.001, respectively.

We then stratified the OP microbial samples to three subgroups to understand how the predominant genera distributed in children with different ages (Figure 2(b)). Except for Veillonella, Rothia, Actinomyces, Atopobium, and Moraxella, the dominated bacterial components in OP of children ≤1 year old differ significantly from that in other two subgroups (Figure 2(b)). None of the top fifteen bacterial genera in OP microbiota alters overtly after 1 year old (Supplementary Table 5). Genus Streptococcus is the most abundant in children ≤1 year old (52.7%) but diminishes to 25.7% (>1 and ≤3 years old) (q-value < 0.001) and 19.5% (>3 years old) (q-value <0.001) (Supplementary Table 5), accompanying with Veillonella, Rothia, and Lactobacillus declined with age (Figure 2(b)) as well. Neisseria, Haemophilus, Leptotrichia, and Prevotella are four OP predominant genera, which increase from 0.6~9.3% to 4.2~22.6% in children >1 year old (p-values ≤ 0.05) (Supplementary Table 5).

4. Discussion

The URT could filter and humidify inhaled air and is colonized by various microbes [21]. ANs and NP microbial commensals primarily extract nutrients from the respiratory epithelium [22, 23] and are easily affected by the skin and external atmosphere. These findings suggest a low diversity in the ANs/NP microbiota and highly enriched Corynebacterium and Staphylococcus, which are dominant in the skin microbiota [3, 24]. Moraxella, Dolosigranulum, and Streptococcus are three typical genera in the ANs and NP, which is in accordance with previous reports [2, 1114]. Microbial exposure aids in the development of host immune tolerance in early life [25, 26]. ANs/NP microbiota-accumulated Corynebacterium and Dolosigranulum were associated with lower risk of acute otitis media and respiratory infection [27], partly explaining the predominance of Corynebacterium and Dolosigranulum in ANs and NP microbiota of selected children. Given the frequent exchange between ANs/NP and exterior environments, various reports demonstrated rapid assemblage of ANs and NP microbiota in the first month of life [14, 15, 28]. In addition, delivery mode and feeding type only imposed effect on NP microbiota in 6 months after birth [14]. Considering small number of children ≤6 months old, our study found little discrepancy of ANs/NP microbiota among children with different ages.

In contrast with the ANs/NP, food ingestion and oesophageal reflux may affect the OP microbial composition, implicating a distinct and more complex microbiota structure in the OP [13, 29]. Our study suggested the development the OP microbiota in the first year of life, which is a so-called critical window for airway development and immune maturation [19] as well as gastrointestinal tract [30]. Previous study identified similar predominant genera in the OP of Canadian children aged 1 to 4.5 years old [31] and OP microenvironment gradually changed with respiratory epithelium development and diet alteration [1, 32], which may trigger later maturation of the OP microbiota compared to ANs and NP. Correspondingly, the microbiota diversity and predominant microbial colonizers of the OP keep stable after 1 year old, which resembles gut microbiota assemblage [32].

URT microbial commensals participate in a stable interaction network under healthy conditions [21] and impaired URT microbiota seemed to predispose to pathogenic infections [13, 21, 29]. Prior study demonstrated that Streptococcus-dominant NP microbiota was extraordinarily associated with allergy [11]. Haemophilus-dominant NP microbiota indicated the high severity of bronchiolitis [33] and the NP microbiota impacts the severity of lower respiratory infection (LRI) [28].

Findings in this study will provide a healthy reference of URT microbiota in a typical southern city in China and boost the understanding of airway diseases and underlying microbial etiology. However, there also exist several limitations, including the shortage of newborn infants, single-centre sampling, and the small sample size of the cohort. Otherwise, a large cohort and longitudinal study of the URT microbiota is also considered in our laboratory.

5. Conclusions

This study provides a critical reference for the normal URT microbiota as well as the site- and age-specific URT microbial structure of healthy children in Shenzhen, China. Additionally, this work will facilitate the understanding of the microbial aetiology in respiratory diseases of Chinese paediatric patients.

Ethical Approval

This study was approved and all methods were conducted under the Ethical Committee of Shenzhen Children’s Hospital with registration number 2016013.

Consent

All children’ parents provided the informed consent.

Conflicts of Interest

The authors declare that there are no conflicts of interest regarding the publication of this article.

Authors’ Contributions

In this work, Shuaicheng Li and Yuejie Zheng managed the project; Hongmei Wang performed sampling; Heping Wang, Qian Zhou, and Xin Feng conducted pathogen detection, sequencing, and analysing, respectively; Heping Wang, Yonghong Yang, and Wenkui Dai interpreted the result and written manuscript. Heping Wang, Wenkui Dai, and Xin Feng contributed equally.

Acknowledgments

This work was supported by Guangdong Medical Research Fund A2016501; Sanming Project of Medicine in Shenzhen SZSM201512030; Shenzhen Public Service Platform for Clinical Drug Trials 20151964; and Shenzhen Science and Technology Project JCYJ20170303155012371. The authors thank Mr. Xiaofeng Lin from EasyPub for polishing revised manuscript. They also thank the staffs of WeHealthGene whose names are not included in the author list, but who contributed to the project.

Supplementary Materials

Supplementary 1. Supplementary Tables. Table S1: sample information; Table S2: confounder analysis; Table S3: intergroup comparison at phylum level: NP-OP, ANs-OP, and ANs-NP; Table S4: intergroup comparison of dominant genera: NP-OP, ANs-OP, and ANs-NP; Table S5: comparison of dominant genera in OP among different ages.

Supplementary 2. Supplementary Figure 1: rarefaction curve of the OTU number to the tag number. All samples’ rarefaction curve reached plateau, which demonstrates that the data is enough for further analysis. The X-coordinate represents the selected tags, and the Y-coordinate stands for the relative OTU number.

Supplementary 3. Supplementary Figure 2: dissimilarity of bacterial community in ANs-NP and ANs-OP. The X-coordinate represents the 4 subgroups with different ages, and Y-coordinate stands for the dissimilarity of bacterial community. represents p-value ⩽ 0.001.

References

  1. A. Sahin-Yilmaz and R. M. Naclerio, “Anatomy and physiology of the upper airway,” Proceedings of the American Thoracic Society, vol. 8, no. 1, pp. 31–39, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. Y. Zhou, H. Gao, and K. A. Mihindukulasuriya, “Biogeography of the ecosystems of the healthy human body,” Genome Biology, vol. 14, 2013. View at Publisher · View at Google Scholar
  3. The Human Microbiome Project Consortium, “Structure, function and diversity of the healthy human microbiome,” Nature, vol. 486, pp. 207–214, 2012. View at Publisher · View at Google Scholar
  4. S. I. Miller, R. K. Ernst, and M. W. Bader, “LPS, TLR4 and infectious disease diversity,” Nature Reviews Microbiology, vol. 3, no. 1, pp. 36–46, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. W. Wu, J. Huang, B. Duan et al., “Th17-stimulating protein vaccines confer protection against Pseudomonas aeruginosa pneumonia,” American Journal of Respiratory and Critical Care Medicine, vol. 186, no. 5, pp. 420–427, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. N. M. Troy and A. Bosco, “Respiratory viral infections and host responses; insights from genomics,” Respiratory Research, vol. 17, no. 1, 2016. View at Publisher · View at Google Scholar
  7. J. C. Brealey, P. D. Sly, P. R. Young, and K. J. Chappell, “Viral bacterial co-infection of the respiratory tract during early childhood,” FEMS Microbiology Letters, vol. 362, no. 10, 2015. View at Publisher · View at Google Scholar
  8. P. D. N'Guessan, H. Haarmann, T. Steiner et al., “The Moraxella catarrhalis-induced pro-inflammatory immune response is enhanced by the activation of the epidermal growth factor receptor in human pulmonary epithelial cells,” Biochemical and Biophysical Research Communications, vol. 450, no. 2, pp. 1038–1044, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. S. N. Lauder, E. Jones, K. Smart et al., “Interleukin-6 limits influenza-induced inflammation and protects against fatal lung pathology,” European Journal of Immunology, vol. 43, no. 10, pp. 2613–2625, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Yang, W. C. Hooper, D. J. Phillips, and D. F. Talkington, “Cytokines in Mycoplasma pneumoniae infections,” Cytokine & Growth Factor Reviews, vol. 15, no. 2-3, pp. 157–168, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. G. Biesbroek, E. Tsivtsivadze, E. A. M. Sanders et al., “Early respiratory microbiota composition determines bacterial succession patterns and respiratory health in children,” American Journal of Respiratory and Critical Care Medicine, vol. 190, no. 11, pp. 1283–1292, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. G. B. Rogers, L. R. Hoffman, M. P. Carroll, and K. D. Bruce, “Interpreting infective microbiota: The importance of an ecological perspective,” Trends in Microbiology, vol. 21, no. 6, pp. 271–276, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. E. S. Charlson, K. Bittinger, A. R. Haas et al., “Topographical continuity of bacterial populations in the healthy human respiratory tract,” American Journal of Respiratory and Critical Care Medicine, vol. 184, no. 8, pp. 957–963, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. A. A. T. M. Bosch, E. Levin, M. A. van Houten et al., “Development of upper respiratory tract microbiota in infancy is affected by mode of delivery,” EBioMedicine, vol. 9, pp. 336–345, 2016. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Mika, I. Mack, I. Korten et al., “Dynamics of the nasal microbiota in infancy: A prospective cohort study,” The Journal of Allergy and Clinical Immunology, vol. 135, no. 4, pp. 905–912, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. J. G. Caporaso, J. Kuczynski, J. Stombaugh et al., “QIIME allows analysis of high-throughput community sequencing data,” Nature Methods, vol. 7, no. 5, pp. 335-336, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Wang, W. Dai, C. Qiu et al., “Mycoplasma pneumoniae and Streptococcus pneumoniae caused different microbial structure and correlation network in lung microbiota,” Journal of Thoracic Disease, vol. 8, no. 6, pp. 1316–1322, 2016. View at Publisher · View at Google Scholar · View at Scopus
  18. B. J. Kelly, I. Imai, K. Bittinger et al., “Composition and dynamics of the respiratory tract microbiome in intubated patients,” Microbiome, vol. 4, article no. 7, 2016. View at Publisher · View at Google Scholar · View at Scopus
  19. C. M. Lloyd and B. J. Marsland, “Lung Homeostasis: Influence of Age, Microbes, and the Immune System,” Immunity, vol. 46, no. 4, pp. 549–561, 2017. View at Publisher · View at Google Scholar
  20. S. Prevaes, W. de Steenhuijsen Piters, K. de Winter-de Groot et al., “The concordance between the microbiome of the upper and lower respiratory tract is investigated in infants with cystic fibrosis,” Journal of Cystic Fibrosis, vol. 14, 2015. View at Publisher · View at Google Scholar
  21. W. A. de Steenhuijsen Piters, E. A. Sanders, and D. Bogaert, “The role of the local microbial ecosystem in respiratory health and disease,” Philosophical Transactions of the Royal Society B: Biological Sciences, vol. 370, no. 1675, 2015. View at Publisher · View at Google Scholar
  22. S. J. Siegel, A. M. Roche, and J. N. Weiser, “Influenza promotes pneumococcal growth during coinfection by providing host sialylated substrates as a nutrient source,” Cell Host & Microbe, vol. 16, no. 1, pp. 55–67, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. M. G. Roy, A. Livraghi-Butrico, A. A. Fletcher et al., “Muc5b is required for airway defence,” Nature, vol. 505, no. 7483, pp. 412–416, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. M. G. Dominguez-Bello, E. K. Costello, M. Contreras et al., “Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 107, no. 26, pp. 11971–11975, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. E. S. Gollwitzer and B. J. Marsland, “Impact of Early-Life Exposures on Immune Maturation and Susceptibility to Disease,” Trends in Immunology, vol. 36, no. 11, pp. 684–696, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Shreiner, H. Gb, and M. C. Noverr, “The microflora hypothesis of allergic disease,” Advances in Experimental Medicine and Biology, vol. 635, pp. 113–134, 2008. View at Publisher · View at Google Scholar
  27. M. M. Pettigrew, A. S. Laufer, J. F. Gent, Y. Kong, K. P. Fennie, and J. P. Metlay, “Upper respiratory tract microbial communities, acute otitis media pathogens, and antibiotic use in healthy and sick children,” Applied and Environmental Microbiology, vol. 78, no. 17, pp. 6262–6270, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. S. M. Teo, D. Mok, K. Pham et al., “The infant nasopharyngeal microbiome impacts severity of lower respiratory infection and risk of asthma development,” Cell Host & Microbe, vol. 17, no. 5, pp. 704–715, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. C. M. Bassis, J. R. Erb-Downward, R. P. Dickson et al., “Analysis of the upper respiratory tract microbiotas as the source of the lung and gastric microbiotas in healthy individuals,” MBio, vol. 6, no. 2, Article ID e00037-15, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Subramanian, S. Huq, T. Yatsunenko et al., “Persistent gut microbiota immaturity in malnourished Bangladeshi children,” Nature, vol. 510, no. 7505, pp. 417–421, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. J. C. Stearns, C. J. Davidson, S. McKeon et al., “Culture and molecular-based profiles show shifts in bacterial communities of the upper respiratory tract that occur with age,” The ISME Journal, vol. 9, no. 5, pp. 1268–1268, 2015. View at Publisher · View at Google Scholar
  32. H. Wopereis, R. Oozeer, K. Knipping, C. Belzer, and J. Knol, “The first thousand days - intestinal microbiology of early life: Establishing a symbiosis,” Pediatric Allergy and Immunology, vol. 25, no. 5, pp. 428–438, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. K. Hasegawa, J. M. Mansbach, N. J. Ajami et al., “Association of nasopharyngeal microbiota profiles with bronchiolitis severity in infants hospitalised for bronchiolitis,” European Respiratory Journal, vol. 48, no. 5, pp. 1329–1339, 2016. View at Publisher · View at Google Scholar · View at Scopus